MORGAN STANLEY PLC/CALL/MERCK & CO./117.5/0.1/21.06.24 Share Price

Warrant

DE000MD7C1A2

Market Closed - Börse Stuttgart 12:03:09 01/06/2024 am IST
0.78 EUR +6.85% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./117.5/0.1/21.06.24
1 month-40.00%
3 months-35.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
31/24/31 0.78 +6.85%
30/24/30 0.73 -10.98%
29/24/29 0.82 -5.75%
28/24/28 0.87 -23.01%
27/24/27 1.13 -2.59%

Delayed Quote Börse Stuttgart

Last update May 01, 2024 at 12:03 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MD7C1A
ISINDE000MD7C1A2
Date issued 24/08/2022
Strike 117.5 $
Maturity 21/06/2024 (19 Days)
Parity 10 : 1
Emission price 0.49
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.61
Lowest since issue 0.116
Spread 0.01
Spread %1.22%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus